[1]
Savithri Desai, Harish.G.Bagewadi, and Harinika G, “Hyperbilirubinemia during Atazanavir treatment in HIV/AIDS patients taking second line ART drugs”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 7, no. 1, pp. 1-6, Apr. 2021.